Real-World Evidence (RWE)
Real-World Evidence (RWE) is clinical evidence about the use and potential benefits or risks of a medical product derived from analysis of real-world data — electronic health records, claims data, registries, patient-generated data, and observational studies — rather than from traditional randomized clinical trials.
The FDA formally recognizes RWE as a supporting evidence category under the 21st Century Cures Act, and uses it in regulatory decision-making for drug and device approvals, post-market surveillance, and label expansions. For pharmaceutical and device communications, RWE has become a major content franchise — published RWE studies indexed in PubMed and covered by STAT News, Endpoints News, and BioPharma Dive earn durable Citation Share inside AI engines on real-world-outcome queries.
See: The Healthcare Pillar.
